Core Scientific, Inc.
CORZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $81,103 | $78,628 | $79,525 | $94,925 |
| % Growth | 3.1% | -1.1% | -16.2% | – |
| Cost of Goods Sold | $77,327 | $73,603 | $71,312 | $90,162 |
| Gross Profit | $3,776 | $5,025 | $8,213 | $4,763 |
| % Margin | 4.7% | 6.4% | 10.3% | 5% |
| R&D Expenses | $0 | $0 | $0 | $5,016 |
| G&A Expenses | $0 | $0 | $40,115 | $35,706 |
| SG&A Expenses | $69,225 | $56,940 | $40,115 | $38,576 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2,870 |
| Other Operating Expenses | $0 | -$25,631 | $10,694 | $954 |
| Operating Expenses | $69,225 | $31,309 | $50,809 | $44,546 |
| Operating Income | -$65,449 | -$26,284 | -$42,596 | -$39,783 |
| % Margin | -80.7% | -33.4% | -53.6% | -41.9% |
| Other Income/Exp. Net | -$81,086 | -$910,357 | $623,494 | -$225,383 |
| Pre-Tax Income | -$146,535 | -$936,641 | $580,898 | -$265,166 |
| Tax Expense | $125 | $158 | $205 | $375 |
| Net Income | -$146,660 | -$936,799 | $580,693 | -$265,541 |
| % Margin | -180.8% | -1,191.4% | 730.2% | -279.7% |
| EPS | -0.46 | -0.042 | 1.44 | -0.6 |
| % Growth | -1,003.1% | -102.9% | 340% | – |
| EPS Diluted | -0.46 | -0.042 | 1.25 | -0.6 |
| Weighted Avg Shares Out | 318,562 | 317,985 | 315,186 | 306,146 |
| Weighted Avg Shares Out Dil | 318,562 | 317,985 | 363,314 | 306,146 |
| Supplemental Information | – | – | – | – |
| Interest Income | $821 | $1,185 | $2,187 | $0 |
| Interest Expense | $0 | $0 | $0 | $1,136 |
| Depreciation & Amortization | $19,073 | $21,484 | $22,407 | $29,155 |
| EBITDA | -$127,462 | -$634 | -$20,183 | -$234,875 |
| % Margin | -157.2% | -0.8% | -25.4% | -247.4% |